24 Healthcare Stocks Moving In Monday's Pre-Market Session

Gainers

• Wright Medical Group, Inc. WMGI stock increased by 31.8% to $29.00 during Monday's pre-market session. The market cap stands at $2.6 billion. The most recent rating by Wells Fargo, on August 12, is at Market Perform, with a price target of $23.00.
• Redhill Biopharma, Inc. RDHL shares rose 30.1% to $9.00.
• Enlivex Therapeutics, Inc. ENLV stock rose 29.0% to $8.36. The market cap seems to be at $270.1 million.
• Evolus, Inc. EOLS shares surged 9.8% to $17.50. The market cap seems to be at $473.0 million. The most recent rating by Mizuho, on September 05, is at Buy, with a price target of $30.00.
• Genfit, Inc. GNFT shares rose 9.2% to $15.02.
• SCYNEXIS, Inc. SCYX shares increased by 8.1% to $1.34. The market cap stands at $61.8 million.
• Karyopharm Therapeutics, Inc. KPTI shares surged 7.7% to $13.51. The market value of their outstanding shares is at $615.7 million.
• OpGen, Inc. OPGN stock moved upwards by 6.6% to $1.45. The market value of their outstanding shares is at $6.7 million.
• Agile Therapeutics, Inc. AGRX stock surged 5.9% to $1.43. The market value of their outstanding shares is at $70.2 million.
• Aphria, Inc. APHA stock moved upwards by 5.8% to $5.49. The market value of their outstanding shares is at $1.7 billion.
• Bausch Health Companies, Inc. BHC shares surged 3.9% to $26.93. The market cap seems to be at $10.2 billion. The most recent rating by Cowen & Co., on October 25, is at Outperform, with a price target of $35.00.
• SELLAS Life Sciences, Inc. SLS stock increased by 3.4% to $0.14. The market cap seems to be at $27.4 million.
• Xenetic Biosciences, Inc. XBIO stock surged 3.1% to $1.33. The market value of their outstanding shares is at $6.5 million.
• Heat Biologics, Inc. HTBX shares rose 2.5% to $0.60. The market cap stands at $18.3 million.
• DBV Technologies, Inc. DBVT shares moved upwards by 2.2% to $7.45.
• Valeritas Holdings, Inc. VLRX stock moved upwards by 2.1% to $1.46. The market cap stands at $10.2 million.
• Clovis Oncology, Inc. CLVS shares rose 2.1% to $3.66. The market cap seems to be at $233.3 million. The most recent rating by Goldman Sachs, on October 08, is at Sell, with a price target of $3.00.
• Amarin Corp, Inc. AMRN stock rose 2.0% to $17.10. The market value of their outstanding shares is at $5.4 billion. The most recent rating by Aegis Capital, on October 31, is at Buy, with a price target of $23.00.

Losers

• AVEO Pharmaceuticals, Inc. AVEO stock plummeted 30.1% to $0.62 during Monday's pre-market session. The market value of their outstanding shares is at $153.4 million. The most recent rating by H.C. Wainwright, on September 11, is at Buy, with a price target of $1.75.
• Omeros, Inc. OMER stock declined 18.9% to $13.14. The market cap stands at $804.8 million.
• Rexahn Pharmaceuticals, Inc. REXN stock decreased by 13.9% to $1.80. The market cap seems to be at $9.3 million.
• Biocept, Inc. BIOC shares plummeted 9.6% to $0.66. The market cap seems to be at $19.2 million.
• IVERIC bio, Inc. ISEE stock declined 4.0% to $3.65. The market cap stands at $46.5 million.
• HEXO, Inc. HEXO shares plummeted 3.2% to $2.11. The market value of their outstanding shares is at $1.2 billion. According to the most recent rating by Seaport Global, on October 14, the current rating is at Neutral.